Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 4.900
-0.100 (-2.00%)
At close: Jul 18, 2025, 5:30 PM CET
Vytrus Biotech Revenue
In the year 2024, Vytrus Biotech had annual revenue of 6.09M EUR with 29.51% growth. Vytrus Biotech had revenue of 3.06M in the half year ending December 31, 2024, with 46.56% growth.
Revenue
6.09M
Revenue Growth
+29.51%
P/S Ratio
6.05
Revenue / Employee
164.60K
Employees
37
Market Cap
36.87M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.37B |
| Laboratorios Farmaceuticos Rovi | 767.47M |
| Almirall | 1.03B |
| Pharma Mar | 175.75M |
| Faes Farma | 524.02M |
| Clínica Baviera | 279.53M |
| Laboratorio Reig Jofre | 340.41M |
| Atrys Health | 218.10M |